Leelyn Smith’s Zimmer Biomet ZBH Stock Holding History

Leelyn Smith’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-66	Closed	-$7K	–	515
2022 Q2	$7K	Hold	66	–	–	﹤0.01%	316
2022 Q1	$8K	Sell	66 -2	-3%	-$241	﹤0.01%	300
2021 Q4	$8K	Hold	68	–	–	﹤0.01%	310
2021 Q3	$10K	Hold	68	–	–	﹤0.01%	283
2021 Q2	$11K	Hold	68	–	–	﹤0.01%	275
2021 Q1	$11K	Hold	68	–	–	﹤0.01%	291
2020 Q4	$10K	Hold	68	–	–	﹤0.01%	278
2020 Q3	$9K	Hold	68	–	–	﹤0.01%	272
2020 Q2	$8K	Hold	68	–	–	﹤0.01%	340
2020 Q1	$7K	Hold	68	–	–	﹤0.01%	269
2019 Q4	$10	Buy	+68	New	+$9.39K	﹤0.01%	265

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Leelyn Smith's ZBH Position: Q3 2022 in Review

Leelyn Smith sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 66 shares — an estimated $7K sold.

Leelyn Smith first reported a position in ZBH in Q4 2019 and held it in 11 quarters. The position peaked at $11K in Q2 2021. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Leelyn Smith reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Leelyn Smith sold 66 Zimmer Biomet shares in Q3 2022, an estimated $7K.
Leelyn Smith first reported a position in Zimmer Biomet in Q4 2019 and held it in 11 quarters.
Leelyn Smith's Zimmer Biomet position peaked at $11K in Q2 2021.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Leelyn Smith's 13F filing for Q3 2022, filed 14 Nov 2022.